Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 21 | 2021 | 214 | 5.510 |
Why?
|
| Drosophila Proteins | 26 | 2020 | 761 | 4.450 |
Why?
|
| Glucosyltransferases | 15 | 2025 | 52 | 4.250 |
Why?
|
| Drosophila | 17 | 2023 | 824 | 3.550 |
Why?
|
| Alagille Syndrome | 4 | 2025 | 49 | 2.900 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 5 | 2022 | 10 | 2.340 |
Why?
|
| Liver | 6 | 2025 | 1848 | 2.230 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2022 | 44 | 2.150 |
Why?
|
| Signal Transduction | 24 | 2025 | 4881 | 2.030 |
Why?
|
| Drosophila melanogaster | 14 | 2022 | 836 | 1.890 |
Why?
|
| Glycosyltransferases | 6 | 2025 | 28 | 1.670 |
Why?
|
| Polysaccharides | 4 | 2021 | 150 | 1.550 |
Why?
|
| Epidermal Growth Factor | 4 | 2018 | 124 | 1.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2023 | 294 | 1.230 |
Why?
|
| Glycosylation | 11 | 2021 | 127 | 1.050 |
Why?
|
| Animals | 47 | 2025 | 36265 | 1.040 |
Why?
|
| Serrate-Jagged Proteins | 5 | 2023 | 38 | 1.000 |
Why?
|
| Jagged-1 Protein | 7 | 2025 | 55 | 0.990 |
Why?
|
| SOXC Transcription Factors | 1 | 2025 | 14 | 0.960 |
Why?
|
| Muscle Development | 1 | 2025 | 76 | 0.940 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2019 | 13 | 0.900 |
Why?
|
| Dependovirus | 1 | 2025 | 146 | 0.870 |
Why?
|
| SOX9 Transcription Factor | 2 | 2025 | 87 | 0.850 |
Why?
|
| Lipolysis | 1 | 2023 | 80 | 0.840 |
Why?
|
| Wings, Animal | 3 | 2017 | 35 | 0.830 |
Why?
|
| Membrane Proteins | 8 | 2023 | 1607 | 0.820 |
Why?
|
| Pentosyltransferases | 3 | 2018 | 21 | 0.810 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 85 | 0.790 |
Why?
|
| Bile Ducts | 2 | 2020 | 54 | 0.780 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2022 | 21 | 0.770 |
Why?
|
| Calcium-Binding Proteins | 4 | 2023 | 337 | 0.730 |
Why?
|
| Genetic Therapy | 1 | 2025 | 727 | 0.680 |
Why?
|
| Transcription Factors | 6 | 2017 | 2700 | 0.660 |
Why?
|
| Fucosyltransferases | 1 | 2019 | 30 | 0.650 |
Why?
|
| Protein Kinases | 2 | 2020 | 342 | 0.630 |
Why?
|
| Glycomics | 1 | 2018 | 16 | 0.620 |
Why?
|
| Genetic Background | 1 | 2018 | 8 | 0.610 |
Why?
|
| Liver Diseases | 2 | 2019 | 388 | 0.590 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 362 | 0.590 |
Why?
|
| Glycoproteins | 1 | 2020 | 378 | 0.580 |
Why?
|
| Xylose | 2 | 2017 | 9 | 0.560 |
Why?
|
| Heterozygote | 2 | 2020 | 716 | 0.550 |
Why?
|
| Imaginal Discs | 1 | 2017 | 11 | 0.550 |
Why?
|
| Sense Organs | 4 | 2006 | 19 | 0.530 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 130 | 0.520 |
Why?
|
| Rare Diseases | 1 | 2018 | 204 | 0.520 |
Why?
|
| Transgenes | 4 | 2014 | 345 | 0.510 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 17 | 0.490 |
Why?
|
| Mice | 13 | 2025 | 18815 | 0.480 |
Why?
|
| Gene Silencing | 3 | 2025 | 251 | 0.470 |
Why?
|
| Photoreceptor Cells | 1 | 2014 | 94 | 0.450 |
Why?
|
| Phenotype | 6 | 2025 | 4518 | 0.440 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 93 | 0.430 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 585 | 0.430 |
Why?
|
| Eye Proteins | 1 | 2014 | 233 | 0.410 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2025 | 37 | 0.410 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2019 | 19 | 0.390 |
Why?
|
| Gene Deletion | 1 | 2015 | 809 | 0.390 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 1328 | 0.380 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2008 | 406 | 0.380 |
Why?
|
| Mutation | 13 | 2020 | 6267 | 0.350 |
Why?
|
| Stem Cells | 3 | 2025 | 750 | 0.340 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 2658 | 0.330 |
Why?
|
| Cell Differentiation | 4 | 2025 | 2027 | 0.320 |
Why?
|
| Genetic Techniques | 1 | 2010 | 109 | 0.320 |
Why?
|
| Embryonic Development | 1 | 2011 | 220 | 0.310 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2020 | 27 | 0.300 |
Why?
|
| Humans | 23 | 2025 | 133290 | 0.290 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2023 | 106 | 0.280 |
Why?
|
| Ligands | 3 | 2018 | 570 | 0.270 |
Why?
|
| Genes, Insect | 2 | 2008 | 126 | 0.260 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4746 | 0.260 |
Why?
|
| Muscle, Skeletal | 2 | 2025 | 1050 | 0.250 |
Why?
|
| Endocytosis | 2 | 2005 | 131 | 0.250 |
Why?
|
| Receptor, Notch2 | 1 | 2025 | 12 | 0.250 |
Why?
|
| Receptor, Notch3 | 1 | 2025 | 12 | 0.250 |
Why?
|
| PAX7 Transcription Factor | 1 | 2025 | 20 | 0.250 |
Why?
|
| Myoblasts | 1 | 2025 | 36 | 0.240 |
Why?
|
| Receptor, Notch1 | 1 | 2025 | 79 | 0.240 |
Why?
|
| Glucose | 4 | 2014 | 924 | 0.240 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 121 | 0.230 |
Why?
|
| Neurons | 5 | 2006 | 2033 | 0.230 |
Why?
|
| Cell Lineage | 2 | 2006 | 369 | 0.230 |
Why?
|
| Zinc Fingers | 1 | 2004 | 122 | 0.220 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2004 | 96 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 1048 | 0.210 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2535 | 0.210 |
Why?
|
| Oocytes | 1 | 2005 | 301 | 0.210 |
Why?
|
| Enterocytes | 1 | 2023 | 75 | 0.210 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 2157 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2020 | 928 | 0.200 |
Why?
|
| Juvenile Hormones | 1 | 2002 | 4 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4786 | 0.190 |
Why?
|
| Body Patterning | 1 | 2002 | 130 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3957 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2006 | 939 | 0.180 |
Why?
|
| Genetic Vectors | 1 | 2025 | 967 | 0.180 |
Why?
|
| Cell Line | 6 | 2017 | 2842 | 0.180 |
Why?
|
| Repressor Proteins | 5 | 2008 | 866 | 0.180 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Cholestasis | 1 | 2023 | 158 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2525 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2023 | 499 | 0.170 |
Why?
|
| Dystroglycans | 1 | 2020 | 7 | 0.170 |
Why?
|
| Lipids | 1 | 2023 | 566 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 783 | 0.160 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 67 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 369 | 0.160 |
Why?
|
| Portal Vein | 1 | 2019 | 95 | 0.150 |
Why?
|
| Hepatocytes | 1 | 2020 | 230 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 2018 | 25 | 0.150 |
Why?
|
| Protein Binding | 4 | 2017 | 1831 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2002 | 1060 | 0.130 |
Why?
|
| Nervous System | 3 | 2006 | 131 | 0.130 |
Why?
|
| Base Sequence | 3 | 2014 | 3169 | 0.130 |
Why?
|
| Peptide Mapping | 1 | 2016 | 42 | 0.130 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 55 | 0.130 |
Why?
|
| Protein Folding | 2 | 2015 | 225 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2018 | 923 | 0.130 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 339 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3171 | 0.120 |
Why?
|
| Growth and Development | 1 | 2015 | 23 | 0.120 |
Why?
|
| Hepatic Insufficiency | 1 | 2015 | 2 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 808 | 0.120 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2015 | 33 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 495 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 229 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 242 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2015 | 49 | 0.120 |
Why?
|
| Molecular Sequence Data | 6 | 2007 | 3970 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 2785 | 0.110 |
Why?
|
| Enzyme Assays | 2 | 2015 | 12 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 127 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1869 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2014 | 452 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 138 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 327 | 0.100 |
Why?
|
| Temperature | 2 | 2011 | 328 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 861 | 0.100 |
Why?
|
| Biomarkers | 1 | 2022 | 3402 | 0.100 |
Why?
|
| Models, Biological | 5 | 2014 | 1533 | 0.100 |
Why?
|
| Receptors, Serotonin | 2 | 2003 | 45 | 0.090 |
Why?
|
| Factor VII | 1 | 2011 | 16 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 151 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3058 | 0.090 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 54 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 116 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 400 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 733 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 544 | 0.080 |
Why?
|
| Seizures | 1 | 2015 | 892 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2011 | 456 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 1158 | 0.070 |
Why?
|
| Apoptosis | 2 | 2005 | 1931 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 384 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 292 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 47 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2896 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 838 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 676 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1760 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 51 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 96 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2006 | 827 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 978 | 0.060 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 43 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 128 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 2003 | 17 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 13107 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 386 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 1754 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 131 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2020 | 14748 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 896 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 289 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 633 | 0.050 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2002 | 2 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2003 | 188 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2804 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 1413 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 710 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 171 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25678 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2005 | 1085 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 1145 | 0.040 |
Why?
|
| Pregnancy | 1 | 2011 | 7487 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 588 | 0.040 |
Why?
|
| Spain | 1 | 2016 | 65 | 0.030 |
Why?
|
| Fucose | 1 | 2016 | 22 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 307 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1693 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 842 | 0.030 |
Why?
|
| Male | 4 | 2020 | 65619 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 110 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 165 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 96 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 166 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 398 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 394 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1300 | 0.030 |
Why?
|
| Alleles | 2 | 2008 | 1703 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 833 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 2 | 2003 | 6 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 310 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1834 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1614 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 926 | 0.020 |
Why?
|
| Female | 2 | 2020 | 71345 | 0.020 |
Why?
|
| Spodoptera | 1 | 2008 | 47 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2008 | 57 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 144 | 0.020 |
Why?
|
| Chromosomes | 1 | 2008 | 165 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 267 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 184 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 232 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 168 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 228 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 222 | 0.020 |
Why?
|
| Cyclin E | 1 | 2005 | 33 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 559 | 0.020 |
Why?
|
| Ataxins | 1 | 2005 | 114 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 907 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 298 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1124 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 3874 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2005 | 162 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 360 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 688 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 115 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 60 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2005 | 163 | 0.010 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 6 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 496 | 0.010 |
Why?
|
| Meiosis | 1 | 2003 | 115 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 628 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 715 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 254 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 295 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 912 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 458 | 0.010 |
Why?
|
| Septum of Brain | 1 | 2000 | 5 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1365 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 315 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31851 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2000 | 481 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2932 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 725 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3206 | 0.010 |
Why?
|